Rakuten Medical, Inc., a San Diego-based biotechnology company, raised $100 million in a Series F fundraising round led by TaiAx Life Science Fund L.P. with participation from Daiwa Securities Group, Sumitomo Mitsui Banking Corporation SMBC, and others.
More on VC News Daily →

